@article{Athanasakis2017-hv,
title = {The Socioeconomic Effects of Uncontrolled Hypertension},
author = {Kostas Athanasakis},
year = {2017},
date = {2017-01-01},
journal = {Curr Vasc Pharmacol},
volume = {16},
number = {1},
pages = {5--9},
address = {United Arab Emirates},
abstract = {BACKGROUND: Hypertension (HT), albeit a modifiable risk factor of
cardiovascular morbidity and mortality, remains one of the main
contributors to the total disease burden internationally and,
thus, inevitably one of the basic cost drivers in healthcare
systems. CONCLUSION: Taking the above into account, this brief
narrative review aims at presenting the main findings of the
international health economics literature on HT with regards to
four key areas: a) the costs attributable to HT, b) the effects
of HT on patient well-being, c) the cost-effectiveness of
pharmaceutical interventions against high blood pressure, and, d)
the costs and benefits of preventive measures against HT. Bearing
in mind the available evidence on disease costs and the
efficiency of interventions, HT must constitute a primary
objective of modern health policy, internationally.},
keywords = {Hypertension; cost; cost-effectiveness; health economics; health-related quality of life},
pubstate = {published},
tppubtype = {article}
}
BACKGROUND: Hypertension (HT), albeit a modifiable risk factor of
cardiovascular morbidity and mortality, remains one of the main
contributors to the total disease burden internationally and,
thus, inevitably one of the basic cost drivers in healthcare
systems. CONCLUSION: Taking the above into account, this brief
narrative review aims at presenting the main findings of the
international health economics literature on HT with regards to
four key areas: a) the costs attributable to HT, b) the effects
of HT on patient well-being, c) the cost-effectiveness of
pharmaceutical interventions against high blood pressure, and, d)
the costs and benefits of preventive measures against HT. Bearing
in mind the available evidence on disease costs and the
efficiency of interventions, HT must constitute a primary
objective of modern health policy, internationally.